
|Podcasts|July 30, 2021
Pharmacy Focus Episode 28: What To Know About Alzheimer Drug Aducanumab
The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
Advertisement
In this week’s episode, we will be discussing the approval of the Alzheimer drug aducanumab with Pamela Spicer, senior analyst at Datamonitor with Informa Pharma Intelligence. If you would like to nominate a pharmacist or pharmacy staff member as a Pharmacy Hero, email AAntrim@pharmacytimes.com!
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
More Dose Adjustments, Similar Outcomes: Ribociclib vs Palbociclib in Practice
4
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
5




































































































































































































